Expression analysis of MET, EGFR, and HER2, and K-ras mutation status in patients with stage II/III gastric cancer enrolled in the ACTS-GC study.
Atsushi Ochiai
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Koji Kitada
Research Funding - Taiho Pharmaceutical
Wataru Ichikawa
Honoraria - Taiho Pharmaceutical
Masanori Terashima
Honoraria - Taiho Pharmaceutical
Issei Kurahashi
Consultant or Advisory Role - Taiho Pharmaceutical
Hitoshi Katai
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Ryoji Kushima
Research Funding - Taiho Pharmaceutical
Mitsuru Sasako
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical